These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical features, pathogenic mechanisms, and new developments in the treatment of systemic sclerosis. Geppert T Am J Med Sci; 1990 Mar; 299(3):193-209. PubMed ID: 2180298 [No Abstract] [Full Text] [Related]
5. Advances in palliative care for the patient with scleroderma. Herrick AL Curr Opin Rheumatol; 1996 Nov; 8(6):555-60. PubMed ID: 9018459 [TBL] [Abstract][Full Text] [Related]
6. Scleroderma and related disorders: therapeutic aspects. Denton CP; Black CM Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):17-35. PubMed ID: 10882212 [TBL] [Abstract][Full Text] [Related]
13. Hand warming as a treatment for Raynaud's phenomenon in systemic sclerosis. Goodfield MJ; Rowell NR Br J Dermatol; 1988 Nov; 119(5):643-6. PubMed ID: 3207617 [TBL] [Abstract][Full Text] [Related]
15. Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma. Cappelli L; Wigley FM Rheum Dis Clin North Am; 2015 Aug; 41(3):419-38. PubMed ID: 26210127 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of systemic sclerosis (except pulmonary arterial hypertension)]. Hachulla E Rev Med Interne; 2007 Dec; 28 Suppl 4():S277-84. PubMed ID: 17977626 [No Abstract] [Full Text] [Related]
17. What is your diagnosis? Progressive systemic sclerosis (scleroderma). Elston DM Cutis; 2005 Dec; 76(6):357, 385-7. PubMed ID: 16438423 [No Abstract] [Full Text] [Related]
18. The treatment of systemic sclerosis. Black CM Adv Exp Med Biol; 1999; 455():271-7. PubMed ID: 10599354 [No Abstract] [Full Text] [Related]